This has been supported by a study that compared healthy controls (n = 36) to patients with either mild cognitive impairment (MCI, n = 39) or AD dementia (n = 27), which demonstrated higher levels of YKL-40 in AD patients compared to controls in CSF samples [212]. The gene discussed is CHI3L1; the disease is Alzheimer disease.